Core Curriculum for Oncology Nursing, 4th Edition
0721603572
9780721603575
Description:
Published in collaboration with the ONS, this text is the definitive source for concepts and practices in oncology nursing and can be used for orientation of nurses to oncology, inservice and continuing education programs for practicing nurses, a basis for curriculum development in graduate programs, and as a review tool for certification. Based on the blueprint of the certification examination by the ONCC (Oncology Nursing Certification Corporation), the book is in outline format to help readers focus on the most important information. Instructor resources available; contact your sales representative for details.
- Covers the entire scope of the specialty ensuring comprehensive coverage
- Outline format helps the reader focus on the most important information
- Effective guide for teaching and learning for in-service, continuing education, and academic programs
- Powerful study tool for the ONCC certification exam
- Tables and figures illustrate complex concepts
* Expanded pain management content.
* New content on nonpharmacologic interventions (e.g. heat massage, imagery).
* New content on alternative therapies.
Best prices to buy, sell, or rent ISBN 9780721603575
Frequently Asked Questions about Core Curriculum for Oncology Nursing, 4th Edition
The price for the book starts from $6.49 on Amazon and is available from 30 sellers at the moment.
If you’re interested in selling back the Core Curriculum for Oncology Nursing, 4th Edition book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Core Curriculum for Oncology Nursing, 4th Edition book, the best buyback offer comes from and is $ for the book in good condition.
The Core Curriculum for Oncology Nursing, 4th Edition book is in very low demand now as the rank for the book is 2,956,337 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.